UK Regulators Advise on Risk Linked to PPIs
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) updated its recommendations on the safety of proton pump inhibitors (PPIs)—such as Prilosec , Nexium
Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.